Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Stefansson

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Scientific Reports|April 26, 2017
Expression of Nestin associates with BRCA1 mutations, a basal-like phenotype and aggressive breast cancerKristi Krüger, Elisabeth Wik, Gøril Knutsvik, et al.
International Journal of Cancer|February 6, 2024
Age-related phenotypes in breast cancer: A population-based studyAmalie A Svanøe, Rasmus O C Humlevik, Gøril Knutsvik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2013
High phospho-Stathmin(Serine38) expression identifies aggressive endometrial cancer and suggests an association with PI3K inhibitionElisabeth Wik, Even Birkeland, Jone Trovik, et al.
Plos One|February 9, 2013
Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancersMaria B Raeder, Even Birkeland, Jone Trovik, et al.
Gynecologic Oncology|July 5, 2014
Endometrial Carcinoma Recurrence Score (ECARS) validates to identify aggressive disease and associates with markers of epithelial-mesenchymal transition and PI3K alterationsE Wik, J Trovik, K Kusonmano, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 6, 2009
Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activationH B Salvesen, S L Carter, M Mannelqvist, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 17, 2008
Drug-sensitive FGFR2 mutations in endometrial carcinomaAmit Dutt, Helga B Salvesen, Tzu-Hsiu Chen, et al.
Nature Genetics|June 28, 2016
The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasisWilliam J Gibson, Erling A Hoivik, Mari K Halle, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 27, 2026
Integrated mutational landscape analysis of endometrial stromal sarcomaTobias M P Hartwich, Seungji Choi, Ayoung Hwang, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Scientific Reports|April 26, 2017
Expression of Nestin associates with BRCA1 mutations, a basal-like phenotype and aggressive breast cancerKristi Krüger, Elisabeth Wik, Gøril Knutsvik, et al.
International Journal of Cancer|February 6, 2024
Age-related phenotypes in breast cancer: A population-based studyAmalie A Svanøe, Rasmus O C Humlevik, Gøril Knutsvik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2013
High phospho-Stathmin(Serine38) expression identifies aggressive endometrial cancer and suggests an association with PI3K inhibitionElisabeth Wik, Even Birkeland, Jone Trovik, et al.
Plos One|February 9, 2013
Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancersMaria B Raeder, Even Birkeland, Jone Trovik, et al.
Gynecologic Oncology|July 5, 2014
Endometrial Carcinoma Recurrence Score (ECARS) validates to identify aggressive disease and associates with markers of epithelial-mesenchymal transition and PI3K alterationsE Wik, J Trovik, K Kusonmano, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 6, 2009
Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activationH B Salvesen, S L Carter, M Mannelqvist, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 17, 2008
Drug-sensitive FGFR2 mutations in endometrial carcinomaAmit Dutt, Helga B Salvesen, Tzu-Hsiu Chen, et al.
Nature Genetics|June 28, 2016
The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasisWilliam J Gibson, Erling A Hoivik, Mari K Halle, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 27, 2026
Integrated mutational landscape analysis of endometrial stromal sarcomaTobias M P Hartwich, Seungji Choi, Ayoung Hwang, et al.
Pageof 7